Page 136 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

112 F. David Carmona, Ana Márquez, Javier Martín et al.

[75] Morahan, G., Huang, D., Ymer, S. I., et al. Linkage disequilibrium of a type 1 diabetes
susceptibility locus with a regulatory IL12B allele. Nat. Genet. 2001; 27:218-221.

[76] Fishman, D., Faulds, G., Jeffery, R., et al. The effect of novel polymorphisms in the
interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an
association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 1998; 102:
1369-1376.

[77] Panoulas, V. F., Stavropoulos-Kalinoglou, A., Metsios, G. S., et al. Association of
interleukin-6 (IL-6)-174G/C gene polymorphism with cardiovascular disease in patients
with rheumatoid arthritis: the role of obesity and smoking. Atherosclerosis 2009; 204:
178-183.

[78] Pascual, M., Nieto, A., Mataran, L., et al. IL-6 promoter polymorphisms in rheumatoid
arthritis. Genes Immun. 2000; 1:338-340.

[79] Saruhan-Direskeneli, G., Bicakcigil, M., Yilmaz, V., et al. Interleukin (IL)-12, IL-2,
and IL-6 gene polymorphisms in Takayasu's arteritis from Turkey. Hum. Immunol.
2006; 67:735-740.

[80] Lopez, M. E., Avila, R. G., Hernandez, E., et al. The Interleukin-1 Gene Cluster
Polymorphisms Are Associated with Takayasu's Arteritis in Mexican Patients. J.
Interferon Cytokine Res. 2013; 33: 369-375.

[81] Fragoso, J. M., Delgadillo, H., Llorente, L., et al. Interleukin 1 receptor antagonist
polymorphisms are associated with the risk of developing acute coronary syndrome in
Mexicans. Immunol. Lett. 2010; 133:106-111.

[82] Olsson, S., Holmegaard, L., Jood, K., et al. Genetic variation within the interleukin-1
gene cluster and ischemic stroke. Stroke 2012; 43:2278-2282.

[83] Bhaskar, V., Yin, J., Mirza, A. M., et al. Monoclonal antibodies targeting IL-1 beta
reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque
formation in Apolipoprotein E-deficient mice. Atherosclerosis 2011; 216:313-320.

[84] Espinola-Zavaleta, N., Soto-Lopez, M. E., Carreon-Torres, E., et al. Altered flow-
mediated vasodilatation, low paraoxonase-1 activity, and abnormal high-density
lipoprotein subclass distribution in Takayasu's arteritis. Circ. J. 2009; 73:760-766.

[85] Huesca-Gomez, C., Soto, M. E., Castrejon-Tellez, V., et al. PON1 gene polymorphisms
and plasma PON1 activities in Takayasu's arteritis disease. Immunol. Lett. 2013; 152:
77-82.

[86] Burns, J. C., Newburger, J. W. Genetics insights into the pathogenesis of Kawasaki
disease. Circ. Cardiovasc. Genet. 2012 Jun.; 5:277-278.

[87] Burgner, D., Davila, S., Breunis, W. B., et al. A genome-wide association study
identifies novel and functionally related susceptibility Loci for Kawasaki disease. PLoS
Genet. 2009; 5.

[88] Khor, C. C., Davila, S., Breunis, W. B., et al. Genome-wide association study identifies
FCGR2A as a susceptibility locus for Kawasaki disease. Nat. Genet. 2011; 43:1241-
1246.

[89] Kim, J. J., Hong, Y. M., Sohn, S., et al. A genome-wide association analysis reveals
1p31 and 2p13.3 as susceptibility loci for Kawasaki disease. Hum. Genet. 2011; 129:
487-495.

[90] Lee, Y. C., Kuo, H. C., Chang, J. S., et al. Two new susceptibility loci for Kawasaki
disease identified through genome-wide association analysis. Nat. Genet. 2012; 44:522-
525.

Complimentary Contributor Copy